BioCorRx (BICX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BICX Stock Alerts $0.75 -0.72 (-48.98%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioCorRx Inc. (BICX)finance.yahoo.com - April 18 at 8:36 AMBioCorRx (OTCMKTS:BICX) Shares Cross Above Fifty Day Moving Average of $0.98americanbankingnews.com - April 17 at 4:06 AMBioCorRx receives new patent for novel compound to treat pain, depression, and schizophreniaseekingalpha.com - April 3 at 4:13 PMBioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophreniaglobenewswire.com - April 3 at 8:30 AMBioCorRx Reports Business Update for 2023globenewswire.com - April 2 at 8:30 AMHow to Win a Business Grant: 4 Entrepreneurs Share Their Tipsmsn.com - February 29 at 8:15 PMBioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUDglobenewswire.com - February 28 at 10:49 AMBIOCORRX INC NEW by BioCorRx Inc. Stock (OTC:BICX), Quotes and News Summarybenzinga.com - February 22 at 3:27 PMBioCorRx Inc. (BICX) stock price, news, quote & history – Yahoo Financenz.finance.yahoo.com - February 13 at 3:29 AMBioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directorsfinance.yahoo.com - February 8 at 2:23 PMCollective Audience And 3 Other Stocks Under $1 Insiders Are Buyingmsn.com - January 18 at 1:12 PMBioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as Presidentfinance.yahoo.com - January 9 at 10:24 AMTAYNX Transamerica High Yield ESG-Class R4seekingalpha.com - January 4 at 10:45 AMCheng Fwa Industrial Ltd (5426)investing.com - January 3 at 1:16 PMBioCorRx Inc: BioCorRx Reports Business Update for the Third Quarter of 2023finanznachrichten.de - November 16 at 3:48 PMBioCorRx Reports Business Update for the Third Quarter of 2023finance.yahoo.com - November 14 at 4:59 PMBioCorRx President Awarded $14K Worth of Stock Optionsbenzinga.com - October 3 at 2:21 PMBioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2023finanznachrichten.de - August 21 at 5:33 AMBioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorderfinance.yahoo.com - August 15 at 10:12 AMBioCorRx Reports Business Update for the Second Quarter of 2023finance.yahoo.com - August 14 at 6:04 PMTokai Holdings Corp (3167)investing.com - July 29 at 9:20 PMFukui Bank Ltd (8362)investing.com - July 29 at 6:18 AMNissha Printing Co Ltd (7915)investing.com - July 28 at 1:38 PMDSC Investment Inc (241520)investing.com - July 18 at 11:58 PMBioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorderfinance.yahoo.com - July 18 at 8:57 AMBioCorRx Inc: BioCorRx Provides Business Update for the First Quarter of 2023finanznachrichten.de - May 16 at 10:31 AMBioCorRx Provides Business Update for the First Quarter of 2023finance.yahoo.com - May 16 at 10:31 AMBioCorRx Provides Business Update for 2022finance.yahoo.com - April 3 at 12:53 PMBioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator Meetingfinance.yahoo.com - March 7 at 5:28 PMBioCorRx to Present at Sequire Biotechnology Conference on February 2ndfinance.yahoo.com - January 27 at 1:42 PMBioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorderfinance.yahoo.com - January 19 at 12:37 PMBioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United Statesfinance.yahoo.com - December 7 at 4:36 PMBioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.finance.yahoo.com - November 22 at 7:27 PMBioCorRx Inc: BioCorRx Provides Business Update for the Third Quarter of 2022finanznachrichten.de - November 15 at 12:24 PMBioCorRx Provides Business Update for the Third Quarter of 2022finance.yahoo.com - November 15 at 12:24 PMBioCorRx to Present at the LD Micro Main Event XV on October 25thfinance.yahoo.com - October 24 at 5:57 PMBioCorRx to Participate at the LD Micro Main Event XVfinance.yahoo.com - October 20 at 1:45 PMBioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorderfinance.yahoo.com - October 13 at 1:20 PM2B3D Shares Addiction Treatment Deliverables from BioCorRx for Phase I of Mental Health Metaverse Platform Betanz.finance.yahoo.com - September 29 at 5:37 PMBICX: Pivotal trial underwayfinance.yahoo.com - September 16 at 11:37 AMBioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conferenceapnews.com - September 6 at 9:36 AMBICX.PK - Biocorrx Inc | Stock Price & Latest News | Reutersreuters.com - September 4 at 10:33 PMBioCorRx Provides Business Update for the Second Quarter of 2022finance.yahoo.com - August 16 at 10:16 AMBioCorRx to Participate in the Benzinga All Access Event on July 15thfinance.yahoo.com - July 13 at 11:38 AMBioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcastfinance.yahoo.com - July 6 at 6:00 PMBioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorderfinance.yahoo.com - June 30 at 9:47 AMBioCorRx Featured on LiveNOW from FOXfinance.yahoo.com - June 17 at 5:29 PMBioCorRx to Present at the LD Micro Invitational XII on June 7thfinance.yahoo.com - May 31 at 11:56 AMBioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Settingfinance.yahoo.com - May 19 at 6:20 PMBioCorRx Business Update for the First Quarter of 2022finance.yahoo.com - May 17 at 6:27 PM Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now BICX Media Mentions By Week BICX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BICX News Sentiment▼0.500.48▲Average Medical News Sentiment BICX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BICX Articles This Week▼20▲BICX Articles Average Week Get BioCorRx News Delivered to You Automatically Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AIH News Today BACK News Today CHEK News Today SRNE News Today COEP News Today IMNN News Today MNPR News Today OTRK News Today TNXP News Today NXGL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BICX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCorRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
